CIK 0001034842
- Accelerated filer
RIGEL PHARMACEUTICALS INC
Sign in to watch- Ticker
- RIGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943248524
- Phone
- +1 650-624-1100
- Business address
- 611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- RIGEL PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-09-03 | PAYAN DONALD G EVP, Pres. Discovery&Research | Sale | −20,000 | $2.56 | $51K | 68,334 |
| 2014-05-21 | RINGROSE PETER S Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2014-05-21 | SHERWIN STEPHEN A Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2014-05-21 | MOOS WALTER H Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2014-05-21 | LYONS GARY A Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2014-05-21 | Goodwin Bradford S Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2014-02-27 | Maynard Ryan D EVP & CFO | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2014-02-27 | VANCE DOLLY EVP Corp. Affairs, G.C., Sect. | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2014-02-27 | Grossbard Elliott B EVP, CMO | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2014-02-27 | RODRIGUEZ RAUL R President & COO | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2014-02-27 | PAYAN DONALD G EVP, Pres. Discovery&Research | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2014-02-27 | GOWER JAMES M CEO & Board Chairman | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2014-02-24 | PAYAN DONALD G EVP, Pres. Discovery&Research | Sale | −20,000 | $3.71 | $74K | 88,334 |
| 2013-11-19 | BVF PARTNERS L P/IL 10% owner | Sale | −331,566 | $2.64 | $876K | 1,123,848 |
| 2013-11-19 | BVF PARTNERS L P/IL 10% owner | Sale | −153,056 | $2.64 | $404K | 646,559 |
| 2013-06-07 | BVF PARTNERS L P/IL 10% owner | Purchase | +24,598 | $3.47 | $85K | 1,455,414 |
| 2013-06-07 | BVF PARTNERS L P/IL 10% owner | Purchase | +8,102 | $3.47 | $28K | 799,615 |
| 2013-05-15 | RINGROSE PETER S Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2013-05-15 | Goodwin Bradford S Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2013-05-15 | RENTON HOLLINGS Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 |
Page 21 of 22 · 423 trades